144 related articles for article (PubMed ID: 37137827)
1. [Significance of soluble PD-L1 in patients with chronic hepatitis B and hepatitis C].
Ke RM; Ouyang LJ; Li WF; Peng XM
Zhonghua Gan Zang Bing Za Zhi; 2023 Feb; 31(2):133-137. PubMed ID: 37137827
[No Abstract] [Full Text] [Related]
2. Increase of Soluble Programmed Cell Death Ligand 1 in Patients with Chronic Hepatitis C.
Yamagiwa S; Ishikawa T; Waguri N; Sugitani S; Kamimura K; Tsuchiya A; Takamura M; Kawai H; Terai S
Int J Med Sci; 2017; 14(5):403-411. PubMed ID: 28539815
[No Abstract] [Full Text] [Related]
3. High levels of soluble programmed death-1 are associated with virological response in chronic hepatitis B patients after antiviral treatment.
Tan N; Luo H; Kang Q; Pan J; Cheng R; Xi H; Chen H; Han Y; Yang Y; Xu X
Virus Res; 2022 Feb; 309():198660. PubMed ID: 34929214
[TBL] [Abstract][Full Text] [Related]
4. [Observation of PD-1
He J; Yao YQ; Xia RX; Qiu TJ; Long L; Wang Y; Jiang Y
Zhonghua Gan Zang Bing Za Zhi; 2022 Mar; 30(3):316-322. PubMed ID: 35462489
[No Abstract] [Full Text] [Related]
5. Association of PD-L1 gene polymorphisms and circulating sPD-L1 levels with HBV infection susceptibility and related liver disease progression.
Xuan Hoan N; Thi Minh Huyen P; Dinh Tung B; Phuong Giang D; Tat Trung N; Tien Sy B; Thi Tuan N; Thi Ngoc Dung D; Reddy Pallerla S; Velavan TP; Hong Bang M; Huu Song L
Gene; 2022 Jan; 806():145935. PubMed ID: 34478821
[TBL] [Abstract][Full Text] [Related]
6. [Programmed cell death protein 1 and its ligands regulate immune balance in allergic rhinitis].
Wen SL; Li F; Zhao F; Zuo JJ; Deng YQ; Zhang W; Tao ZZ
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2020 Apr; 55(4):384-390. PubMed ID: 32306637
[No Abstract] [Full Text] [Related]
7. Soluble programmed death-1 is predictive of hepatitis B surface antigen loss in chronic hepatitis B patients after antiviral treatment.
Tan N; Luo H; Kang Q; Pan JL; Cheng R; Xi HL; Chen HY; Han YF; Yang YP; Xu XY
World J Clin Cases; 2021 Jul; 9(21):5812-5821. PubMed ID: 34368300
[TBL] [Abstract][Full Text] [Related]
8. Soluble programmed death-1 is a useful indicator for inflammatory and fibrosis severity in chronic hepatitis B.
Zhou L; Li X; Huang X; Chen L; Gu L; Huang Y
J Viral Hepat; 2019 Jul; 26(7):795-802. PubMed ID: 30578715
[TBL] [Abstract][Full Text] [Related]
9. Pre-treatment serum levels of soluble programmed cell death-ligand 1 predict prognosis in patients with hepatitis B-related hepatocellular carcinoma.
Han X; Gu YK; Li SL; Chen H; Chen MS; Cai QQ; Deng HX; Zuo MX; Huang JH
J Cancer Res Clin Oncol; 2019 Feb; 145(2):303-312. PubMed ID: 30267213
[TBL] [Abstract][Full Text] [Related]
10. Profiles of serum soluble programmed death-1 and programmed death-ligand 1 levels in chronic hepatitis B virus-infected patients with different disease phases and after anti-viral treatment.
Xia J; Huang R; Chen Y; Liu Y; Wang J; Yan X; Zhang Z; Wu C
Aliment Pharmacol Ther; 2020 Jun; 51(11):1180-1187. PubMed ID: 32363582
[TBL] [Abstract][Full Text] [Related]
11. Serum soluble programmed cell death 1 levels predict spontaneous functional cure in inactive carriers with chronic hepatitis B.
Hu HH; Jeng WJ; Pan MH; Luo WS; Chang CL; Huang YT; Su CY; Chiang CT; Jen CL; Chien YC; Lu SN; Wang LY; Huang LR; Lee MH; Liu J; Nguyen MH; Chen CJ; Yang HI
Aliment Pharmacol Ther; 2022 Mar; 55(5):558-567. PubMed ID: 35032052
[TBL] [Abstract][Full Text] [Related]
12. Clinical Significance of Dynamics of Programmed Death Ligand-1 Expression on Circulating CD14
Huang ZY; Xu P; Li JH; Zeng CH; Song HF; Chen H; Zhu YB; Song YY; Lu HL; Shen CP; Zhang XG; Wu MY; Wang XF
Viral Immunol; 2017 Apr; 30(3):224-231. PubMed ID: 28005469
[TBL] [Abstract][Full Text] [Related]
13. Longitudinal fluctuations in PD1 and PD-L1 expression in association with changes in anti-viral immune response in chronic hepatitis B.
Wenjin Z; Chuanhui P; Yunle W; Lateef SA; Shusen Z
BMC Gastroenterol; 2012 Aug; 12():109. PubMed ID: 22894700
[TBL] [Abstract][Full Text] [Related]
14. Serum interleukin-37 concentrations and HBeAg seroconversion in chronic HBV patients during telbivudine treatment.
Li C; Ji H; Cai Y; Ayana DA; Lv P; Liu M; Jiang Y
J Interferon Cytokine Res; 2013 Oct; 33(10):612-8. PubMed ID: 23697556
[TBL] [Abstract][Full Text] [Related]
15. Soluble programmed cell death protein 1 (sPD-1) and the soluble programmed cell death ligands 1 and 2 (sPD-L1 and sPD-L2) in lymphoid malignancies.
Mortensen JB; Monrad I; Enemark MB; Ludvigsen M; Kamper P; Bjerre M; d'Amore F
Eur J Haematol; 2021 Jul; 107(1):81-91. PubMed ID: 33721375
[TBL] [Abstract][Full Text] [Related]
16. Circulating level of sPD-1 and PD-1 genetic variants are associated with hepatitis B infection and related liver disease progression.
Huyen PTM; Dung DTN; Weiß PJ; Hoan PQ; Giang DP; Uyen NT; Van Tuan N; Trung NT; Velavan TP; Song LH; Hoan NX
Int J Infect Dis; 2022 Feb; 115():229-236. PubMed ID: 34910956
[TBL] [Abstract][Full Text] [Related]
17. [Expression of soluble programmed death-1, soluble programmed death ligand 1 proteins and immune status in patients with oral lichen planus].
Luo L; Shu M; Li S; Cai Y
Zhonghua Kou Qiang Yi Xue Za Zhi; 2015 Oct; 50(10):585-9. PubMed ID: 26757624
[TBL] [Abstract][Full Text] [Related]
18. Association of Cytokines with Alanine Aminotransferase, Hepatitis B Virus Surface Antigen and Hepatitis B Envelope Antigen Levels in Chronic Hepatitis B.
Li MH; Lu Y; Zhang L; Wang XY; Ran CP; Hao HX; Zhang D; Qu XJ; Shen G; Wu SL; Cao WH; Qi TL; Liu RY; Hu LP; Chang M; Hua WH; Liu SA; Wan G; Xie Y
Chin Med J (Engl); 2018 Aug; 131(15):1813-1818. PubMed ID: 30058578
[TBL] [Abstract][Full Text] [Related]
19. The association between sPD-1 levels versus liver biochemistry and viral markers in chronic hepatitis B patients: a comparative study of different sPD-1 assays.
Jeng WJ; Chen CH; Wang YW; Pan MH; Lin CW; Lin CY; Yang HI
Virol J; 2022 Mar; 19(1):59. PubMed ID: 35361235
[TBL] [Abstract][Full Text] [Related]
20. Serum vitamin D and vitamin-D-binding protein levels in children with chronic hepatitis B.
Huang CZ; Zhang J; Zhang L; Yu CH; Mo Y; Mo LY
World J Gastroenterol; 2021 Jan; 27(3):255-266. PubMed ID: 33519140
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
